A MODIFYING LOCUS FOR FAMILIAL ADENOMATOUS POLYPOSIS MAY BE PRESENT ON CHROMOSOME 1P35-P36

Citation
Ipm. Tomlinson et al., A MODIFYING LOCUS FOR FAMILIAL ADENOMATOUS POLYPOSIS MAY BE PRESENT ON CHROMOSOME 1P35-P36, Journal of Medical Genetics, 33(4), 1996, pp. 268-273
Citations number
19
Categorie Soggetti
Genetics & Heredity
Journal title
ISSN journal
00222593
Volume
33
Issue
4
Year of publication
1996
Pages
268 - 273
Database
ISI
SICI code
0022-2593(1996)33:4<268:AMLFFA>2.0.ZU;2-Q
Abstract
Mutations of the APC gene cause familial adenomatous polyposis (FAP) i n humans and multiple intestinal neoplasia (Min) in laboratory mouse s trains. A dominant modifying gene (Mom1), which partially suppresses t he min phenotype, has been mapped to mouse chromosome 4. This region i s syntenic with human chromosome 1p35-p36. The phospholipase A2 (Pla2s ) locus is an excellent candidate for Mom1 and the equivalent human lo cus PLA2G2A is found on chromosome 1p35. It does not necessarily follo w, however, than any modifier of mouse polyposis also influences human disease. In order to test whether a locus on Ip modifies FAP, subject s from 28 FAP families have been typed at microsatellite loci on this chromosome arm. The severity of their duodenal polyposis has also been assessed by endoscopy. Pedigree (led score) linkage analysis found no evidence of a simple, dominant modifying gene, comparable with the ac tion of Mom1 in inbred mouse strains. Given the more complex genetic a nd environmental interactions likely to exist in outbred human populat ions, it is probably more appropriate to use tests which do not specif y a mode of inheritance. Using these methods of analysis, the data sug gest that a locus on chromosome 1p35-p36 may influence the severity of duodenal FAP.